Versant Capital Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
Versant Capital Management's TWST Position: Q3 2026 in Review
Versant Capital Management reduced its Twist Bioscience (TWST) stake by 2.1% in Q3 2026, selling an estimated $741 and leaving 283 shares worth $54.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1342.
Versant Capital Management first reported a position in TWST in Q2 2023 and has held it in 14 quarters since. 431 funds tracked by Wall St. Rank hold TWST as of Q3 2026.
- Versant Capital Management held 283 shares of Twist Bioscience worth $54.7K as of Q3 2026.
- Versant Capital Management sold 6 Twist Bioscience shares in Q3 2026, an estimated $741.
- Twist Bioscience made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1342 holding.
- Versant Capital Management first reported a position in Twist Bioscience in Q2 2023 and has held it in 14 quarters since.
- 431 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.